Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: Evidence from a regression discontinuity design

BACKGROUND: In clinical trials, several SARS-CoV-2 vaccines were shown to reduce risk of severe COVID-19 illness. Local, population-level, real-world evidence of vaccine effectiveness is accumulating. We assessed vaccine effectiveness for community-dwelling New York City (NYC) residents using a quas...

Descripción completa

Detalles Bibliográficos
Autores principales: Greene, Sharon K., Levin-Rector, Alison, McGibbon, Emily, Baumgartner, Jennifer, Devinney, Katelynn, Ternier, Alexandra, Sell, Jessica, Kahn, Rebecca, Kishore, Nishant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694652/
https://www.ncbi.nlm.nih.gov/pubmed/34961848
http://dx.doi.org/10.1016/j.jvacx.2021.100134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694652/
https://www.ncbi.nlm.nih.gov/pubmed/34961848
http://dx.doi.org/10.1016/j.jvacx.2021.100134

Ejemplares similares